Thus, immunohistochemical analysis of ETAR expression may serve as a convenient, low-cost technique for identifying breast cancer patients with a poor chance of response to chemotherapy and, therefore, potential candidates for more individualised treatments. Here, EDNRA is linked to breast cancer.